Vineet Laboratories Limited

NSE VINEETLAB.NS

Vineet Laboratories Limited EBT Margin for the year ending March 31, 2024: 0.24%

Vineet Laboratories Limited EBT Margin is 0.24% for the year ending March 31, 2024, a -74.76% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Vineet Laboratories Limited EBT Margin for the year ending March 31, 2023 was 0.96%, a -80.44% change year over year.
Vineet Laboratories Limited EBT Margin for the year ending March 31, 2022 was 4.89%, a 193.29% change year over year.
Vineet Laboratories Limited EBT Margin for the year ending March 31, 2021 was 1.67%.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

NSE: VINEETLAB.NS

Vineet Laboratories Limited

CEO	Mr. Gaddam Venkata Ramana
IPO Date	June 15, 2021
Location	India
Headquarters	5-5-160, Malleswari Nilayam
Employees	79
Sector	Healthcare
Industries Pharmaceuticals Chemicals & Advanced Materials Clinical Trials Composite Materials Cosmetics Personal Care Petrochemicals Plastics

Description

Vineet Laboratories Limited engages in the research, development, and manufacture of active pharmaceutical ingredients and fine chemicals in India. The company was incorporated in 2016 and is based in Hyderabad, India.

Key trends

Past 5 years